Indivior Pharmaceuticals Inc
INDV
Rank in Stocks
#4015
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Share Price
$32.56
Last synced: 2026-10-16
Market Cap
$4.06B
Change (1 day)
-3.15%
Change (1 year)
33.01%
Country
US
Trade Indivior Pharmaceuticals Inc (INDV)
Category
Healthcare
EPS for Indivior Pharmaceuticals Inc (INDV)
EPS as of June 2026 TTM: $2.84
According to Indivior Pharmaceuticals Inc latest financial reports and stock price the company's current EPS (TTM) is $2.84. At the end of 2023 the company had a EPS of $0.01 an increase over its 2022 EPS that were of $-0.37.
EPS history for Indivior Pharmaceuticals Inc from 2016 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $2.84 | 14,100.00% |
| 2024 | $0.02 | 3.42% |
| 2023 | $0.01 | -103.95% |
| 2022 | $-0.37 | -126.81% |
| 2021 | $1.38 | -227.78% |
| 2020 | $-1.08 | -213.68% |
| 2019 | $0.95 | -47.51% |
| 2018 | $1.81 | 330.95% |
| 2017 | $0.42 | 90.91% |
| 2016 | $0.22 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -80.41% |
IN
|
